Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
LFSC vs LABU
Shared holdings
14
LFSC covered by LABU
10.93%
LABU covered by LFSC
10.93%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 40 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
LFSC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| COGENT BIOSCIENCES INC | 9.04% | |
| LIVANOVA PLC | 7.36% | |
| TRANSMEDICS GROUP INC | 5.26% | |
| MIRUM PHARMACEUTICALS INC | 4.84% | |
| TRAVERE THERAPEUTICS INC | 4.62% | |
| SPYRE THERAPEUTICS INC | 4.40% | |
| UNITED THERAPEUTICS CORP DEL | 4.35% | |
| GUARDANT HEALTH INC | 4.32% | |
| WAVE LIFE SCIENCES LTD | 4.21% | |
| SAVARA INC | 4.03% | |
| KALVISTA PHARMACEUTICALS INC | 3.80% | |
| NEKTAR THERAPEUTICS | 3.61% | |
| ICU MEDICAL INC | 3.03% | |
| TREVI THERAPEUTICS INC | 2.84% | |
| BRIDGEBIO PHARMA INC | 2.56% | |
| ACADIA PHARMACEUTICALS INC | 2.44% | |
| INTEGER HOLDINGS CORP | 2.18% | |
| AXSOME THERAPEUTICS INC | 2.15% | |
| COLLEGIUM PHARMACEUTICAL INC | 2.06% | |
| MADRIGAL PHARMACEUTICALS INC | 1.76% | |
| CERIBELL INC | 1.70% | |
| GLOBUS MEDICAL INC | 1.60% | |
| CORCEPT THERAPEUTICS INC | 1.51% | |
| WAYSTAR HOLDING CORP | 1.46% | |
| LUMEXA IMAGING H | 1.38% | |
| CYTOKINETICS INC | 1.38% | |
| BILLIONTOONE INC | 1.33% | |
| XERIS BIOPHARMA HOLDINGS INC | 1.31% | |
| ALPHATEC HOLDINGS INC | 1.09% | |
| RADNET INC | 1.07% | |
| HINGE HEALTH INC | 1.07% | |
| SOLENO THERAPEUTICS INC | 1.06% | |
| CORVUS PHARMACEUTICALS INC | 1.00% | |
| INSMED INC | 0.93% | |
| AVEANNA HEALTHCARE HOLDINGS INC | 0.80% | |
| KORRO BIO INC | 0.78% | |
| F/m US Treasury 6 Month Bill ETF | 0.66% | |
| F/m Ultrashort Treasury Inflation-Protected Security TIPS ETF | 0.56% | |
| NEOGENOMICS INC | 0.44% | |
| U.S. Bank Money Market Deposit Account | 0.00% |
LABU (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 7.43% | |
| US ULTRA BOND CBT Sep25 | 7.26% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 6.27% | |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | 1.71% | |
| APELLIS PHARMACEUTICALS INC | 1.44% | |
| REVOLUTION MEDICINES INC | 1.27% | |
| TRAVERE THERAPEUTICS INC | 1.25% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.11% | |
| TWIST BIOSCIENCE CORP | 1.10% | |
| SUMMIT THERAPEUTICS INC | 1.09% | |
| ALKERMES PLC | 1.07% | |
| TG THERAPEUTICS INC | 1.06% | |
| MADRIGAL PHARMACEUTICALS INC | 1.06% | |
| BEAM THERAPEUTICS INC | 1.02% | |
| APOGEE THERAPEUTICS INC | 0.98% | |
| SCHOLAR ROCK HOLDING CORP | 0.95% | |
| PRAXIS PRECISION MEDICINES INC | 0.95% | |
| EXELIXIS INC | 0.94% | |
| MIRUM PHARMACEUTICALS INC | 0.93% | |
| UNITED THERAPEUTICS CORP DEL | 0.92% | |
| NATERA INC | 0.92% | |
| CELCUITY INC | 0.92% | |
| CRISPR Therapeutics A.G. Series A | 0.92% | |
| KRYSTAL BIOTECH INC | 0.91% | |
| PROTAGONIST THERAPEUTICS INC | 0.90% | |
| NEUROCRINE BIOSCIENCES INC | 0.89% | |
| INCYTE CORP | 0.89% | |
| CG ONCOLOGY INC | 0.89% | |
| CYTOKINETICS INC | 0.89% | |
| NUVALENT INC-A | 0.88% | |
| IONIS PHARMACEUTICALS INC | 0.88% | |
| BRIDGEBIO PHARMA INC | 0.88% | |
| VAXCYTE INC | 0.88% | |
| KYMERA THERAPEUTICS INC | 0.88% | |
| BIOGEN INC | 0.87% | |
| COGENT BIOSCIENCES INC | 0.87% | |
| PTC THERAPEUTICS INC | 0.87% | |
| INSMED INC | 0.86% | |
| ALNYLAM PHARMACEUTICALS INC | 0.85% | |
| ROIVANT SCIENCES | 0.85% | |
| HALOZYME THERAPEUTICS INC | 0.84% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.83% | |
| SPYRE THERAPEUTICS INC | 0.83% | |
| SOLENO THERAPEUTICS INC | 0.82% | |
| ABBVIE INC | 0.82% | |
| AMGEN INC | 0.81% | |
| REGENERON PHARMACEUTICALS INC | 0.80% | |
| ULTRAGENYX PHARMA INC | 0.80% | |
| ACADIA PHARMACEUTICALS INC | 0.80% | |
| RHYTHM PHARMACEUTICALS INC | 0.80% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.